Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00503_DB01624> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00503_DB01624 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00503_DB01624 label "DDI between Ritonavir and Zuclopenthixol - Ritonavir, a strong CYP2D6 inhibitor, may increase the serum concentration of zuclopenthixol by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zuclopenthixol if ritonavir is initiated, discontinued or dose changed. [drugbank_resource:DB00503_DB01624]" assertion.
- drugbank_resource:DB00503_DB01624 identifier "drugbank_resource:DB00503_DB01624" assertion.
- drugbank_resource:DB00503_DB01624 title "DDI between Ritonavir and Zuclopenthixol - Ritonavir, a strong CYP2D6 inhibitor, may increase the serum concentration of zuclopenthixol by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zuclopenthixol if ritonavir is initiated, discontinued or dose changed." assertion.